Latest News

AstraZeneca’s Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons / Image credit: ©Sundry Phtography/AdobeStock
AstraZeneca’s Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons

May 16th 2024

Sipavibart met both dual primary endpoints in the SUPERNOVA phase 3 trial.

STIs in Adolescents and Young Adults: Trends, Management, More
STIs in Adolescents and Young Adults: Trends, Management, More

May 13th 2024

Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine
Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine

May 10th 2024

FDA Approves New Antibiotic for Uncomplicated UTI: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves New Antibiotic for Uncomplicated UTI: Daily Dose

May 3rd 2024

COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose / image credit: ©New Africa/AdobeStock
COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose

April 30th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.